Latest Breaking News On - Platform licensees - Page 4 : comparemela.com

REGENXBIO to Participate in the Jefferies CNS/Neuro Summit

ROCKVILLE, Md., Oct. 5, 2023 /PRNewswire/ REGENXBIO Inc. today announced it will participate in the Jefferies CNS/Neuro Summit on Thursday, October 12, 2023. Jefferies CNS/Neuro.

New yorkUnited statesChris brinzeyDana cormackCorporate communicationsTechnology platform licenseesTechnology platformNeuro summitPlatform licensees

REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society

RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne that includes an optimized transgene for a novel microdystrophin, continues to be.

United statesDana cormackAravindhan veerapandiyanOlivier danosChris brinzeyClinical program updatesTechnology platformInternational congressCorporate communicationsManufacturing innovation centerWorld muscle societyExchange commissionTechnology platform licenseesSecurities exchangeBiologics license applicationDuchenne muscular dystrophy

REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNEtm Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society

REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNEtm Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesOlivier danosAravindhan veerapandiyanChris brinzeyDana cormackWorld muscle societyTechnology platform licenseesCorporate communicationsSecurities exchangeClinical program updatesTechnology platformExchange commissionInternational congressManufacturing innovation centerInterim clinical dataAnnual international congress

REGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Society

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the 28th Annual Congress of the World Muscle Society, taking place in.

United statesJahannaz dastgirChris brinzeyDana cormackAravindhan veerapandiyanClinical developmentTechnology platform licenseesCorporate communicationsWorld muscle societyTechnology platformAnnual congressSenior directorArkansas childrenPlatform licenseesRegenxbio inc

REGENXBIO to Participate in Upcoming Investor Conferences

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual.

New yorkUnited statesChris brinzeyTechnology platformTechnology platform licenseesMorgan stanleyAnnual global healthcareChat dateChat timeGlobal healthcarePlatform licenseesRegenxbio inc